PUBLISHER: The Business Research Company | PRODUCT CODE: 1942778
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942778
Elastography imaging is a non-invasive diagnostic technology designed to assess the rigidity of organs and various body components. This method involves utilizing painless, low-frequency vibrations to determine the stiffness of tissues and organs, aiding in the diagnosis of related disorders.
Two primary modes of elastography imaging are ultrasound and magnetic resonance. Ultrasound, also known as sonography, is an imaging technique that employs high-frequency sound waves to visualize the interior organs and connective tissues such as muscles. This method is valuable for identifying the root causes of discomfort, edema, and diseases affecting the body's internal organs. Elastography imaging finds applications in various medical fields, including radiology, cardiology, obstetrics, urology, vascular, orthopedic, musculoskeletal, and others. These applications are utilized by hospitals, ambulatory surgery centers, and other healthcare facilities.
Tariffs are impacting the elastography imaging market by increasing costs of imported imaging transducers, sensors, electronic components, and advanced software modules. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on imported imaging systems, while Asia-Pacific faces higher equipment procurement costs. These tariffs are raising capital expenditure requirements for healthcare providers. However, they are also encouraging regional manufacturing, localized system integration, and increased development of cost-effective elastography imaging solutions.
The elastography imaging market research report is one of a series of new reports from The Business Research Company that provides elastography imaging market statistics, including elastography imaging industry global market size, regional shares, competitors with a elastography imaging market share, detailed elastography imaging market segments, market trends and opportunities, and any further data you may need to thrive in the elastography imaging industry. This elastography imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The elastography imaging market size has grown rapidly in recent years. It will grow from $3.87 billion in 2025 to $4.27 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to increasing prevalence of liver and musculoskeletal disorders, expansion of diagnostic imaging services, rising adoption of ultrasound-based diagnostics, growing clinical awareness of tissue stiffness assessment, availability of advanced imaging modalities.
The elastography imaging market size is expected to see rapid growth in the next few years. It will grow to $6.41 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to increasing adoption of AI-assisted imaging analysis, rising demand for early-stage disease diagnosis, expansion of elastography use in oncology and cardiology, growing investments in advanced imaging infrastructure, increasing preference for non-invasive diagnostic techniques. Major trends in the forecast period include increasing adoption of shear wave elastography, rising use of non-invasive diagnostic imaging, growing integration of elastography with ultrasound systems, expansion of multi-organ diagnostic applications, enhanced focus on early disease detection.
The anticipated increase in the elastography imaging market is expected to be driven by the growing incidence of chronic liver and breast cancer. Chronic liver and breast cancer involve the uncontrolled growth and multiplication of liver cells, leading to life-threatening conditions. Elastography, a technique based on ultrasound (US), is commonly utilized in hepatology to assess liver stiffness in individuals with chronic liver disease. Consequently, the rising prevalence of chronic liver and breast cancer is poised to fuel the growth of the elastography imaging market. For example, data from the 'Cancer Facts And Figures 2023' report by the American Cancer Society, a nationwide voluntary health organization in the United States, revealed an increase in new cases of liver and intrahepatic bile duct cancer in females, rising from 12,640 in 2020 to 13,230 in 2023.
Major companies in the elastography imaging devices market are increasingly focusing on developing advanced solutions, such as premium ultrasound systems, to improve tissue stiffness assessment, enhance diagnostic accuracy, and streamline clinical workflows. Premium ultrasound systems are sophisticated imaging devices offering high-resolution imaging, faster processing, and specialized features like elastography, 3D/4D imaging, and AI-assisted diagnostics to support clinical precision. For example, in November 2024, Shenzhen Mindray Bio-medical Electronics Co., Ltd., a China-based manufacturer, launched the Resona A20, a premium ultrasound system designed to provide advanced imaging and AI-powered clinical tools for radiology and multi-specialty applications. The system integrates Acoustic Intelligence Technology (AIT) and next-generation AFM transducers to deliver exceptional image quality across diverse clinical scenarios. It features AI-driven tools such as Smart Breast, Smart Thyroid, and Automated Liver STE to optimize workflow and diagnostic accuracy. Key innovations include super-resolution contrast-enhanced ultrasound for microcirculation imaging, multi-parametric liver and breast tools including visco-elastography for tissue stiffness evaluation, and ultra-micro angiography with high-frame-rate imaging for detailed visualization of blood flow and anatomical structures.
In January 2024, Mindray North America Inc., a medical device company based in the United States, joined forces with Aegle Medical Solutions Inc. to incorporate advanced medical imaging solutions aimed at improving patient monitoring. Through this collaboration, Mindray and Aegle Medical Solutions intend to advance the development and integration of elastography imaging technologies, ultimately enhancing patient diagnosis and monitoring in healthcare environments. Aegle Medical Solutions Inc. is also a medical technology company located in the United States.
Major companies operating in the elastography imaging market are Canon Medical Systems Corporation, Esaote S.p.A., GE Healthcare Technologies Inc., Koninklijke Philips N.V., Mindray Bio-Medical Electronics Co. Ltd., Samsung Medison Co. Ltd., Siemens Healthineers AG, Toshiba America Medical Systems Inc., SuperSonic Imagine, Resoundant Inc., Shimadzu Corporation, BK Medical Holding Company Inc., SonoScape Medical Corp., Hitachi Medical Systems, Fujifilm Holdings Corporation, Exact Imaging Inc., Echosens, Konica Minolta Healthcare Americas Inc., QT Ultrasound LLC, Healcerion Co. Ltd., EDAP TMS Inc.
Asia-pacific was the largest region in the elastography imaging market in 2025. The regions covered in the elastography imaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the elastography imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The elastography imaging market consists of sales of one-dimensional transient elastography, point shear wave elastography, and two-dimensional shear wave elastography. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Elastography Imaging Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses elastography imaging market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for elastography imaging ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The elastography imaging market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.